Ann Childress: recent publications

ADHD diagnoses among adults are growing faster than ever in the U.S. despite the absence of formal clinical guidelines for the accurate evaluation and treatment of the condition after childhood.

June 4, 2023The head of the Food and Drug Administration (FDA) blames the persistent ADHD medication shortage, in part, on a surge in stimulant use by people with ADHD, who he suggests may not all truly need the drugs. In a new interview with WebMD’s John Whyte, M.D., FDA commissioner Robert M.

January 10, 2023Psychiatrist, ADHD expert, and ADDitude contributor Joseph Biederman, M.D., passed away late last week, just days before he was scheduled to receive a Lifetime Achievement Award from the American Professional Society of ADHD and Related Disorders (APSARD), which he co-founded, honoring his decades of groundbreaking ADHD research and advocacy.Biederman, age 75, served as Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD at Massachusetts General Hospital (MGH), Director of the Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorders at MGH, and Professor of Psychiatry at Harvard Medical School.Considered the father of pediatric psychopharmacology, Biederman dedicated his career to examining the causes, diagnosis, and ADHD treatment across the lifespan.“He was truly a giant in our field with a brilliant mind and compelling personality,” wrote APSARD president Ann Childress, M.D., on the organization’s website. “As one of the most highly cited child and adolescent psychiatrists in the world, he changed the course of pediatric psychopharmacology.